GS
ARKG icon

GTS Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

GTS Securities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-177,300
Closed -$4.54M – 1428
2024
Q3 		$4.54M Sell
177,300
-149,000
-46% -$3.79M 0.01% 955
2024
Q2 		$7.66M Sell
326,300
-101,300
-24% -$2.56M 0.02% 618
2024
Q1 		$12.3M Buy
427,600
+144,900
+51% +$4.36M 0.02% 426
2023
Q4 		$9.28M Buy
282,700
+208,300
+280% +$5.66M 0.02% 650
2023
Q3 		$2.07M Buy
+74,400
New +$2.43M ﹤0.01% 1486

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

GTS Securities's ARKG Position: Q2 2026 in Review

GTS Securities reduced its ARK Genomic Revolution ETF (ARKG) stake by 23% in Q2 2026, selling an estimated $416K and leaving 42,653 shares worth $1.79M. The position accounts for 0.04% of the portfolio, ranked #270.

GTS Securities first reported a position in ARKG in Q3 2023 and has held it in 11 quarters since. The position peaked at $7.44M in Q2 2024. 273 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • GTS Securities held 42,653 shares of ARK Genomic Revolution ETF worth $1.79M as of Q2 2026.
  • GTS Securities sold 13,071 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $416K.
  • ARK Genomic Revolution ETF made up 0.04% of GTS Securities's portfolio in Q2 2026, its #270 holding.
  • GTS Securities first reported a position in ARK Genomic Revolution ETF in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's ARK Genomic Revolution ETF position peaked at $7.44M in Q2 2024.
  • 273 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.